Pharmacogenetics of membrane transporters: an update on current approaches
- PMID: 19950006
- PMCID: PMC6362991
- DOI: 10.1007/s12033-009-9220-6
Pharmacogenetics of membrane transporters: an update on current approaches
Abstract
This review provides an overview of the pharmacogenetics of membrane transporters including selected ABC transporters (ABCB1, ABCC1, ABCC2, and ABCG2) and OATPs (OATP1B1 and OATP1B3). Membrane transporters are heavily involved in drug clearance and alters drug disposition by actively transporting substrate drugs between organs and tissues. As such, polymorphisms in the genes encoding these proteins may have significant effects on the absorption, distribution, metabolism and excretion of compounds, and may alter pharmacodynamics of many agents. This review discusses the techniques used to identify substrates and inhibitors of these proteins and subsequently to assess the effect of genetic mutation on transport, both in vitro and in vivo. A comprehensive list of substrates for the major drug transporters is included. Finally, studies linking transporter genotype with clinical outcomes are discussed.
References
-
- Borst P, Evers R, Kool M, & Wijnholds J (2000). A family of drug transporters: The multidrug resistance-associated proteins. Journal of the National Cancer Institute, 92, 1295–1302. - PubMed
-
- Dean M, Rzhetsky A, & Allikmets R (2001). The human ATP-binding cassette (ABC) transporter superfamily. Genome Research, 11, 1156–1166. - PubMed
-
- Gottesman MM, & Ambudkar SV (2001). Overview: ABC transporters and human disease. Journal of Bioenergetics and Biomembranes, 33, 453–458. - PubMed
-
- Lepper ER, Nooter K, Verweij J, Acharya MR, Figg WD, & Sparreboom A (2005). Mechanisms of resistance to anticancer drugs: The role of the polymorphic ABC transporters ABCB1 and ABCG2. Pharmacogenomics, 6, 115–138. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials